Cybin Inc.

Public

Toronto, OntarioHealthcarehttps://www.helus.com/

Cybin Inc. is now publicly traded

The data on this page reflects Cybin Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Other

Sep 1, 2026

Company Overview

Cybin Inc. is a clinical-stage pharmaceutical company that develops proprietary novel serotonergic agonists for the treatment of mental health disorders.

Sector

Healthcare

AI Layer

Non-AI

Keywords

psychedelic medicinepsychedelic stocksbiopharmaceuticalmental health therapeuticsclinical-stage biotechdrug discoverypsilocybin analogpsychedelic-assisted therapyclinical trialsdeuterated DMTbiotechmental healthpharma R&Dnovel therapeutics

Cybin Inc. Comparables

Compare Cybin Inc. with similar companies based on industry and business-model similarity.

Cybin Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
AtaiBeckley Inc.	85%
Ceruvia Lifesciences	83%
Freedom Biosciences	78%

View all Comparables

Cybin Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Other	Sep 1, 2026
Early Stage VC	Jul 16, 2026
Early Stage VC	Jul 16, 2026
Private Placement	Mar 23, 2026

View all Funding Rounds

Cybin Inc. Investors

Notable investors and investment history

Cybin Inc. investors
Investor	Rounds
RA Capital Management	Private Placement
Rosalind Advisors	Private Placement
Altium Capital	Private Placement
Deep Track Capital	Private Placement
Logos Capital	Private Placement
Acorn Bioventures	Private Placement
Octagon Capital Advisors	Private Placement

View all Investors

Cybin Inc. Filings

Explore SEC and related filing metadata, where available.

Cybin Inc. filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersToronto, Ontario

Employee Range51

Year Founded2019

Last FundingSep 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?